SME Times is powered by   
Search News
Just in:   • Key equity market indices flat, Sensex at 30,141 pts  • Axis Bank's Q4 net profit down 43 pc  • SEBI allows options trading in commodities market  • Trump's administration unveils tax cut principles  • Trump decides to keep Nafta for now 
Last updated: 23 Feb, 2017  
 Pharma


Gland Pharma FDI proposal referred to Cabinet panel
SME Times News Bureau | 25 Apr, 2017
Foreign Investment Promotion Board (FIPB) has recommended the Rs 4,315-crore investment proposal of Gland Pharma Ltd to the Cabinet Committee on Economic Affairs (CCEA) for approval, an official statement said on Monday.
  Read more....
'Govt policy would succeed if generic drug quality improves'
SME Times News Bureau | 25 Apr, 2017
The Centre's steps to make doctors prescribe drugs by their generic names and not by their brand names may not have material impact without steps for improving the quality standards for drugs, investment banking firm Jefferies has said.
  Read more....
Muted fourth quarter expected for pharma sector: Jefferies
SME Times News Bureau | 07 Apr, 2017
The Indian pharmaceutical sector is expected to have a muted fourth quarter of last fiscal due to weak growth in US business, pricing while FY18 is likely to dominate the results, said investment banking firm Jefferies.
  Read more....
Lupin receives FDA approval for tablets, oral solution
SME Times News Bureau | 01 Mar, 2017
Pharma major Lupin Limited on Tuesday said that it has received final approval for its Oxycodone and Acetaminophen tablets and sodium, potassium and magnesium sulphate oral solution from the US Food and Drug Administration (FDA).
  Read more....
Pharma pricing regulator cuts stent prices by up to 85 pc
SME Times News Bureau | 15 Feb, 2017
In a major measure of relief to cardiac patients in India, the government on Tuesday fixed the ceiling price of coronary stents which are used to open up blocked arteries.
  Read more....
Trump's decision could hit Indian pharma exporters
SME Times News Bureau | 01 Feb, 2017
Foreshadowing "Buy American" moves that could affect the largest market for Indian pharmaceutical companies, US President Donald Trump told drug makers on Monday to bring back manufacturing to the United States.
  Read more....
Biocon gets Rs 460 cr insulin order from Malaysia
SME Times News Bureau | 27 Jan, 2017
Biotech major Biocon on Thursday said its Malaysian subsidiary has won a Rs 460 crore order to supply recombinant human insulin to the Malaysian health ministry.
  Read more....
Zydus arm acquires six drugs from MSD
SME Times News Bureau | 29 Dec, 2016
Pharma major Zydus Cadila on Wednesday announced that its healthcare arm had acquired six brands from US drug maker MSD and its subsidiaries for an undisclosed amount.
  Read more....
Cabinet approves sale of surplus land of 4 pharma PSUs
SME Times News Bureau | 29 Dec, 2016
The Union Cabinet chaired by Prime Minister Narendra Modi on Wednesday approved need-based sale of surplus land of Hindustan Antibiotics Ltd (HAL), Indian Drugs & Pharmaceuticals Ltd (IDPL), Rajasthan Drugs & Pharmaceuticals Ltd (RDPL) and Bengal Chemicals & Pharmaceuticals Ltd (BCPL) to meet their outstanding liabilities.
  Read more....
Cipla plans to raise Rs 4,000 crore
SME Times News Bureau | 20 Dec, 2016
Pharma major Cipla on Monday said that it plans to raise Rs 4,000 crore through the issue of various securities, subject to regulatory approvals.
  Read more....
 
  Customs Exchange Rates
Currency Import Export
US Dollar
65.55
63.85
UK Pound
84.25
81.45
Euro
70.65
68.20
Japanese Yen 60.45 58.40
As on 27 Apr, 2017
  Daily Poll
Is Rupee appreciation a cause of concern for Indian exports?
 Yes
 No
 Can't say
  Commented Stories
» Starting an import export business: Basic guide for beginners(9)
» Monsoon delight(4)
» Govt rejects Congress's claim, says GeM most transparent platform(2)
» GST will not bring major hike in tax burden: Official(1)
» List of items for which anti dumping duties has been levied with related notifications(1)
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter